Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-05-07 5:00 pm Purchase | 13G | PMV PHARMACEUTICALS INC PMVP | Euclidean Capital LLC | 4,673,823 10.4% | 494,407 (+11.83%) | View |
| 2021-02-16 4:00 pm Purchase | 13G | PMV PHARMACEUTICALS INC PMVP | Nextech V Oncology S.C.S. SICAV-SIF | 2,528,290 5.6% | 2,528,290 (New Position) | View |
| 2021-02-12 7:50 pm Sale | 13G | PMV PHARMACEUTICALS INC PMVP | VIKING GLOBAL INVESTORS LP | 2,364,062 5.3% | -277,778 (-10.51%) | View |
| 2021-02-12 4:00 pm Purchase | 13G | PMV PHARMACEUTICALS INC PMVP | Euclidean Capital LLC | 4,179,416 9.3% | 4,179,416 (New Position) | View |
| 2021-02-12 08:11 am Purchase | 13G | PMV PHARMACEUTICALS INC PMVP | Avoro Capital Advisors LLC | 2,350,267 5.3% | 2,350,267 (New Position) | View |
| 2021-02-12 06:07 am Purchase | 13G | PMV PHARMACEUTICALS INC PMVP | INTERWEST PARTNERS X LP | 6,469,911 14.5% | 6,469,911 (New Position) | View |
| 2020-10-05 5:23 pm Purchase | 13D | PMV PHARMACEUTICALS INC PMVP | ORBIMED ADVISORS LLC | 6,589,330 14.7% | 6,589,330 (New Position) | View |
| 2020-10-05 5:04 pm Purchase | 13G | PMV PHARMACEUTICALS INC PMVP | VIKING GLOBAL INVESTORS LP | 2,641,840 6.1% | 2,641,840 (New Position) | View |
| 2020-09-30 4:33 pm Purchase | 13G | PMV PHARMACEUTICALS INC PMVP | Boxer Capital LLC | 2,268,236 5.1% | 2,268,236 (New Position) | View |